PubMed

Madelung's disease as a rare cause of obstructive sleep apnea.

Fonseca VA, Alves C, Marques H, Camacho E, Saraiva AP.

J Bras Pneumol. 2009 Oct;35(10):1053-6.PMID: 19918637 [PubMed - in process]Related articlesFree article

Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.

Staels B, Fonseca VA.

Diabetes Care. 2009 Nov;32 Suppl 2:S237-45. No abstract available. PMID: 19875558 [PubMed - in process]Related articles

Defining and characterizing the progression of type 2 diabetes.

Fonseca VA.

Diabetes Care. 2009 Nov;32 Suppl 2:S151-6. No abstract available. PMID: 19875543 [PubMed - in process]Related articles

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.

Goldfine AB, Fonseca VA, Jones MR, Wang AC, Ford DM, Truitt KE.

Horm Metab Res. 2009 Oct 27. [Epub ahead of print]PMID: 19862667 [PubMed - as supplied by publisher]Related articles

Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes among U.S. Adults.

Carson AP, Reynolds K, Fonseca VA, Muntner P.

Diabetes Care. 2009 Oct 6. [Epub ahead of print]PMID: 19808920 [PubMed - as supplied by publisher]Related articles

Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.

Rhoads GG, Kosiborod M, Nesto RW, Fonseca VA, Lu SE, Zhang Q, Foody JM.

Am J Cardiol. 2009 Oct 1;104(7):910-6.PMID: 19766755 [PubMed - indexed for MEDLINE]Related articles

Systematic review: glucose control and cardiovascular disease in type 2 diabetes.

Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J.

Ann Intern Med. 2009 Sep 15;151(6):394-403. Epub 2009 Jul 20. Review.PMID: 19620144 [PubMed - indexed for MEDLINE]Related articles

Demystifying incretin therapy for type 2 diabetes. Introduction.

Fonseca VA.

Eur J Intern Med. 2009 Jul;20 Suppl 2:S301-2. Epub 2009 Jun 18. No abstract available. PMID: 19580948 [PubMed - indexed for MEDLINE]Related articles

Impact of a natural disaster on diabetes: exacerbation of disparities and long-term consequences.

Fonseca VA, Smith H, Kuhadiya N, Leger SM, Yau CL, Reynolds K, Shi L, McDuffie RH, Thethi T, John-Kalarickal J.

Diabetes Care. 2009 Sep;32(9):1632-8. Epub 2009 Jun 19.PMID: 19542210 [PubMed - indexed for MEDLINE]Related articles

The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.

Goldfine AB, Fonseca VA.

Postgrad Med. 2009 May;121(3 Suppl 1):13-8. Review.PMID: 19494473 [PubMed - indexed for MEDLINE]Related articles

Demystifying incretin therapy for type 2 diabetes. Introduction.

Fonseca VA.

Am J Med. 2009 Jun;122(6 Suppl):S1-2. No abstract available. PMID: 19464423 [PubMed - indexed for MEDLINE]Related articles

Emerging concepts in the pathophysiology of type 2 diabetes mellitus.

Surampudi PN, John-Kalarickal J, Fonseca VA.

Mt Sinai J Med. 2009 Jun;76(3):216-26. Review.PMID: 19421965 [PubMed - indexed for MEDLINE]Related articles

Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress.

Murthy SN, Sukhanov S, McGee J, Greco JA, Chandra S, Delafontaine P, Kadowitz PJ, McNamara DB, Fonseca VA.

Mol Cell Biochem. 2009 Apr 10. [Epub ahead of print]PMID: 19360379 [PubMed - as supplied by publisher]Related articles

Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Bakris GL, Fonseca VA, Sharma K, Wright EM.

Kidney Int. 2009 Jun;75(12):1272-7. Epub 2009 Apr 8. Review.PMID: 19357717 [PubMed - indexed for MEDLINE]Related articles

Animal models of catheter-induced intimal hyperplasia in type 1 and type 2 diabetes and the effects of pharmacologic intervention.

McNamara DB, Murthy SN, Fonseca AN, Desouza CV, Kadowitz PJ, Fonseca VA.

Can J Physiol Pharmacol. 2009 Jan;87(1):37-50. Review.PMID: 19142214 [PubMed - indexed for MEDLINE]Related articles

Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome.

Zappe DH, Sowers JR, Hsueh WA, Haffner SM, Deedwania PC, Fonseca VA, Keeling L, Sica DA.

J Clin Hypertens (Greenwich). 2008 Dec;10(12):894-903.PMID: 19120715 [PubMed - indexed for MEDLINE]Related articles

Dipeptidyl peptidase-4 as a new target of action for type 2 diabetes mellitus: a systematic review.

Wani JH, John-Kalarickal J, Fonseca VA.

Cardiol Clin. 2008 Nov;26(4):639-48. Review.PMID: 18929237 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.

Goldberg RB, Fonseca VA, Truitt KE, Jones MR.

Arch Intern Med. 2008 Jul 28;168(14):1531-40.PMID: 18663165 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of type 2 diabetes: oral agents, insulin, and injectables.

Fonseca VA, Kulkarni KD.

J Am Diet Assoc. 2008 Apr;108(4 Suppl 1):S29-33. Review.PMID: 18358251 [PubMed - indexed for MEDLINE]Related articles

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.

Fonseca VA, Rosenstock J, Wang AC, Truitt KE, Jones MR.

Diabetes Care. 2008 Aug;31(8):1479-84. Epub 2008 May 5.PMID: 18458145 [PubMed - indexed for MEDLINE]Related articlesFree article

Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies.

Rao AD, Kuhadiya N, Reynolds K, Fonseca VA.

Diabetes Care. 2008 Aug;31(8):1672-8. Epub 2008 May 5.PMID: 18458139 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of insulin on the endothelium.

Fonseca VA.

Endocrinol Metab Clin North Am. 2007 Dec;36 Suppl 2:20-6. Review.PMID: 18407031 [PubMed - indexed for MEDLINE]Related articles

Pharmacological treatment of the insulin resistance syndrome in people without diabetes.

Fonseca VA, Bratcher C, Thethi T.

Metab Syndr Relat Disord. 2005 Winter;3(4):332-8. No abstract available. PMID: 18370733 [PubMed - in process]Related articles

Inflammation, insulin resistance, and atherosclerosis.

Theuma P, Fonseca VA.

Metab Syndr Relat Disord. 2004 Jun;2(2):105-13.PMID: 18370641 [PubMed - in process]Related articles

Management of hyperhomocysteinemia.

Chan E, Fonseca VA.

Metab Syndr Relat Disord. 2003 Jun;1(2):159-70.PMID: 18370637 [PubMed - in process]Related articles

Effect of pharmacological treatments for diabetes on homocysteine.

Asnani S, Chan E, Murthy SN, McNamara DB, Fonseca VA.

Metab Syndr Relat Disord. 2003 Jun;1(2):149-58.PMID: 18370636 [PubMed - in process]Related articles

PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease.

Asnani S, Theuma P, Fonseca VA.

Metab Syndr Relat Disord. 2003 Mar;1(1):23-32.PMID: 18370623 [PubMed]Related articles

Identification and treatment of prediabetes to prevent progression to type 2 diabetes.

Fonseca VA.

Clin Cornerstone. 2007;8(2):10-8; discussion 19-20. Review.PMID: 18357952 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy in type 2 diabetes. Introduction.

Fonseca VA.

Clin Cornerstone. 2007;8(2):8-9. No abstract available. PMID: 18357951 [PubMed - indexed for MEDLINE]Related articles

The decrease in microalbuminuria with carvedilol therapy is not enhanced by concurrent use of a statin.

Bell DS, McGill JB, Fonseca VA.

Endocr Pract. 2007 Nov-Dec;13(7):808-9. No abstract available. PMID: 18194941 [PubMed - indexed for MEDLINE]Related articles

Identification and treatment of prediabetes to prevent progression to type 2 diabetes.

Fonseca VA.

Clin Cornerstone. 2008;9(2):51-9; discussion 60-1.PMID: 19410162 [PubMed - indexed for MEDLINE]Related articles

Early identification and treatment of insulin resistance: impact on subsequent prediabetes and type 2 diabetes.

Fonseca VA.

Clin Cornerstone. 2007;8 Suppl 7:S7-18. Review.PMID: 18159645 [PubMed - indexed for MEDLINE]Related articles

Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.

Fonseca VA.

Am J Med. 2007 Sep;120(9 Suppl 2):S18-25. Review.PMID: 17826042 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular effects of peroxynitrite.

Uppu RM, Nossaman BD, Greco AJ, Fokin A, Murthy SN, Fonseca VA, Kadowitz PJ.

Clin Exp Pharmacol Physiol. 2007 Sep;34(9):933-7. Review.PMID: 17645643 [PubMed - indexed for MEDLINE]Related articles

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):80i-89i. Epub 2007 Apr 17.PMID: 17599428 [PubMed - indexed for MEDLINE]Related articles

The role of iron in diabetes and its complications.

Swaminathan S, Fonseca VA, Alam MG, Shah SV.

Diabetes Care. 2007 Jul;30(7):1926-33. Epub 2007 Apr 11. Review. No abstract available. PMID: 17429063 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidants in chronic kidney disease.

Shah SV, Baliga R, Rajapurkar M, Fonseca VA.

J Am Soc Nephrol. 2007 Jan;18(1):16-28. Epub 2006 Dec 13. Review.PMID: 17167116 [PubMed - indexed for MEDLINE]Related articlesFree article

Commentary: Of HOPEs and DREAMs: the quest to prevent type 2 diabetes.

Fonseca VA, Kahn SE.

J Clin Endocrinol Metab. 2006 Dec;91(12):4762-3. Epub 2006 Oct 24. No abstract available. PMID: 17062761 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease.

Fonseca VA.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):713-20; quiz 721-2. Review.PMID: 17028485 [PubMed - indexed for MEDLINE]Related articles

The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus.

Vasudevan AR, Burns A, Fonseca VA.

Treat Endocrinol. 2006;5(5):273-86.PMID: 17002487 [PubMed - in process]Related articles

The metabolic syndrome, hyperlipidemia, and insulin resistance.

Fonseca VA.

Clin Cornerstone. 2005;7(2-3):61-72. Review.PMID: 16473262 [PubMed - indexed for MEDLINE]Related articles

Diabetes treatments have differential effects on nontraditional cardiovascular risk factors.

Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR.

J Diabetes Complications. 2006 Jan-Feb;20(1):14-20.PMID: 16389162 [PubMed - indexed for MEDLINE]Related articles

Hyperhomocysteinemia exacerbates the development of intimal hyperplasia in Sprague-Dawley rats: Alleviation by rosiglitazone.

Murthy S, Fonseca V, McNamara D.

Exp Clin Cardiol. 2005 Fall;10(3):154-9.PMID: 19641680 [PubMed - in process]Related articlesFree article

Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.

Deedwania PC, Fonseca VA.

Am J Med. 2005 Sep;118(9):939-47. Review.PMID: 16164876 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.

Granberry MC, Fonseca VA.

Am J Cardiovasc Drugs. 2005;5(3):201-9. Review.PMID: 15901207 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.

Murthy SN, Obregon DF, Chattergoon NN, Fonseca NA, Mondal D, Dunne JB, Diez JG, Jeter JR Jr, Kadowitz PJ, Agrawal KC, McNamara DB, Fonseca VA.

Metabolism. 2005 May;54(5):645-52.PMID: 15877295 [PubMed - indexed for MEDLINE]Related articles

Potential cardiovascular benefits of insulin sensitizers.

Kunhiraman BP, Jawa A, Fonseca VA.

Endocrinol Metab Clin North Am. 2005 Mar;34(1):117-35. Review.PMID: 15752925 [PubMed - indexed for MEDLINE]Related articles

Role of insulin secretagogues and insulin sensitizing agents in the prevention of cardiovascular disease in patients who have diabetes.

Jawa AA, Fonseca VA.

Cardiol Clin. 2005 May;23(2):119-38. Review.PMID: 15694742 [PubMed - indexed for MEDLINE]Related articles

Erectile dysfunction: interrelationship with the metabolic syndrome.

Matfin G, Jawa A, Fonseca VA.

Curr Diab Rep. 2005 Feb;5(1):64-9. Review.PMID: 15663920 [PubMed - indexed for MEDLINE]Related articles

Decreasing restenosis following angioplasty: the potential of peroxisome proliferator-activated receptor gamma agonists.

Fonseca VA, Diez J, McNamara DB.

Diabetes Care. 2004 Nov;27(11):2764-6. Review. No abstract available. PMID: 15505021 [PubMed - indexed for MEDLINE]Related articlesFree article